Victor W. van Beusechem
Chief Tech/Sci/R&D Officer bij ORCA Therapeutics BV
Profiel
Victor W.
van Beusechem is currently the Chief Scientific Officer at ORCA Therapeutics BV.
Previously, he worked as a Senior Scientist at Introgene BV and Janssen Vaccines & Prevention BV.
He holds a doctorate degree from the University of Leiden and an undergraduate degree from Vrije Universiteit Amsterdam.
Actieve functies van Victor W. van Beusechem
Bedrijven | Functie | Begin |
---|---|---|
ORCA Therapeutics BV
ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Victor W. van Beusechem
Bedrijven | Functie | Einde |
---|---|---|
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Chief Tech/Sci/R&D Officer | 01-01-1998 |
Introgene BV | Chief Tech/Sci/R&D Officer | 01-01-1998 |
Opleiding van Victor W. van Beusechem
University of Leiden | Doctorate Degree |
Vrije Universiteit Amsterdam | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Introgene BV | Health Technology |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
ORCA Therapeutics BV
ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Health Technology |